Business
PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics
Dallas, TX, March 11, 2026 (GLOBE NEWSWIRE) -- PatentVest announced the completion of a strategic intellectual property engagement with Porosome Therapeutics, Inc., a biotechnology company developing a first-in-class therapeutic platform designed to restore cellular secretion mechanisms. The collaboration focused on evaluating and strengthening Porosome Therapeutics’ intellectual property portfolio to support future partnerships, commercialization efforts, and capital strategy initiatives. Paten
About this update from Mdb Capital Holdings, Llc
[{"type":"image","alt":"PatentVest, Inc.","displaySize":"","headline":null,"caption":"PatentVest, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":46,"url":"https://media.zenfs.com/en/globenewswire.com/903ef35cea9541b906719a7d0c61f50c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/V7aZLEAz72CgkduiVkMrSw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTY0O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/903ef35cea9541b906719a7d0c61f50c","width":300,"height":46}},"lazy":false},{"type":"text","content":"Dallas, TX, March 11, 2026 (GLOBE NEWSWIRE) -- PatentVest announced the completion of a strategic intellectual property engagement with Porosome Therapeutics, Inc., a biotechnology company developing a first-in-class therapeutic platform designed to restore cellular secretion mechanisms.","length":288,"tagName":"p"},{"type":"text","content":"The collaboration focused on evaluating and strengthening Porosome Therapeutics’ intellectual property portfolio to support future partnerships, commercialization efforts, and capital strategy initiatives. PatentVest conducted a comprehensive IP portfolio audit, global patent landscape analyses, competitive benchmarking, and strategic partner assessment.","length":356,"tagName":"p"},{"type":"text","content":"Porosome Therapeutics is advancing Porosome Reconstitution Platforms (PRPs), a novel approach to restore cells' native secretory machinery. Unlike traditional therapies that suppress or modulate secretion pathways, the technology is designed to reconstruct the supramolecular porosome complex, the universal docking and fusion machinery responsible for cellular secretion.","length":376,"tagName":"p"},{"type":"text","content":"The strategic analysis confirmed that Porosome Therapeutics occupies a distinct and defensible intellectual property position within the emerging field of secretion restoration technologies, with minimal direct competitive overlap in structural porosome reconstitution.","length":269,"tagName":"p"},{"type":"text","content":""The intellectual property landscape in cellular therapeutics is incredibly crowded, but Porosome Therapeutics has successfully carved out a highly defensible white space," said Will Rosellini, CIPO of PatentVest. "Our analysis clearly shows that by focusing on the structural reconstitution of the porosome complex rath...